American Society of Clinical Oncology (ASCO)

JCO Precision Oncology Conversations

Health EN ↓ 83 episodes

JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.

Be sure to visit the podcast's website and support the creator: ascopubs.org

Author

American Society of Clinical Oncology (ASCO)

Category

Health

Podcast website

ascopubs.org

Latest episode

Nov 3, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Pancreatic Imaging Findings in BRCA1/BRCA2/ATM/PALB2 Carriers 03.11.2026

JCO PO author Dr. Bryson Katona shares insights into the JCO PO article, " Longitudinal Pancreatic Imaging Findings in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes Undergoing Pancreatic Cancer Surveillance: A Prospective PRECEDE Consortium Study. " Host Dr. Rafeh Naqash and Dr. Katona discuss how, in this largest reported cohort of BRCA1, BRCA2, ATM, and PALB2 heterozygotes undergoing PC surveillanc...

Assessment of 2022 CMMRD Diagnostic Criteria 02.11.2026

JCO PO author Melyssa Aronson shares insights into the JCO PO article, " Assessment of the 2022 Constitutional Mismatch Repair Deficiency syndrome (CMMRD) diagnostic criteria using the International Replication Repair Deficiency Consortium (IRRDC) ." Host Dr. Rafeh Naqash and Professor Aronson discuss how refinement of CMMRD diagnostic criteria may address atypical presentation and discordant func...

EPCAM Deletion Architecture Defines Distinct Cancer Phenotype 02.11.2026

JCO PO authors Dr. Kristin Kohler, Heather Hampel, and Dr. Michael Hall share insights into the JCO PO article, " Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk ." Host Dr. Rafeh Naqash and guests discuss how the findings provide new insights into the molecular and clinical heterogeneity of germline deletions involving EPCAM. LINK TO FULL TRANSCRIPT

JCO PO Article Insights: Tumor-informed ctDNA in Early Triple Negative Breast Cancer 28.10.2026

In this JCO PO Article Insights episode, host Dr. Carolyn Lineen summarizes the article, "Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab" by Balic and colleagues. LINK TO FULL TRANSCRIPT

EMR-Based Nudge Improves Molecular Testing in Early-Stage NSCLC 21.10.2026

JCO PO authors Dr. Melina Marmarelis and Dr. Charu Aggarwal at University of Pennsylvania share insights into the JCO PO article, " EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage NSCLC ." Host Dr. Rafeh Naqash and guests discuss how embedding behavioral nudges within clinical workflows can help overcome barriers to biomarker testing in early-stage NSCLC. LINK TO FU...

JCO PO Article Insights: CTCs as Biomarkers in GBM 30.09.2026

In this episode of JCO Precision Oncology Article Insights, host Jiasen He summarizes the article, " Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring ," by Lessi and colleagues. LINK TO FULL TRANSCRIPT

A Decade of Data: JCO PO and the TAPUR Study 16.09.2026

JCO PO Editor-in-Chief Emeritus Dr. James Ford and Founding PI, ASCO TAPUR Study , Dr. Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study and its relationship with the journal. Host Dr. Rafeh Naqash and guests discuss the inception/history of the TAPUR study, its future, and advances in precision medicine over the past decade. L...

JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology 26.08.2026

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology " by Schwartz and colleagues. LINK TO FULL TRANSCRIPT

cfDNA Epigenetics for Toxicity Monitoring 19.08.2026

JCO PO authors Dr. James Hadfield, Dr. Grace Yiqing Zhao, and Dr. Julia Elvin at AstraZeneca share insights into the JCO PO article, " Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals? " Host Dr. Rafeh Naqash and guests discuss emerging evidence that cfDNA methylation profiling provides sensitive, specific signals of tissue injury across mu...

JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors 29.07.2026

In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, " Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study ," by Roberts and colleagues. LINK TO FULL TRANSCRIPT

ALK+ Squamous and Adenosquamous NSCLC 15.07.2026

JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, " Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers ." Host Dr. Rafeh Naqash and Dr. Miao discuss the clinicogenomic characteristics and treatment outcomes of patients with ALK+ squamous an...

JCO PO Article Insights: Genomics of MTAP Loss and Co-Alteration Landscape 24.06.2026

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms " by Dean C. Pavlick and colleagues. LINK TO FULL TRANSCRIPT

Immune Checkpoint Blockade in dMMR/MSI-H Advanced UTUC 17.06.2026

JCO PO authors Dr. Matthew Campbell and Dr. Mohammad Moussa at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, Texas, share insights into their article, " Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. " Host Dr. Rafeh Naqash and Drs. Campbell and Moussa d...

JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer 27.05.2026

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, " EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorectal Cancer " byTakahashi,  et al. LINK TO FULL TRANSCRIPT

Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions 20.05.2026

JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, " CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions ". Host Dr. Rafeh Naqash and Dr. Patil discuss the anti-tumor activity and safety data of seribantumab from the CRESTONE study (NCT043832...

JCO PO Article Insights: Circulating Cancer Genome Atlas Study 5-year Outcomes 29.04.2026

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis " bySwanton et al. LINK TO FULL TRANSCRIPT

JCO PO Article Insights: Analytical Validation of Tumor-Informed ctDNA Assays for MRD 25.03.2026

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation" by Baden et al. TRANSCRIPT Jordan Goldstein: Hello, and welcom...

Oncotype DX Breast Recurrence Score® Results from Paired CNB & SE Specimens 25.02.2026

In this JCO Precision Oncology Article Insights episode, host Dr. Carolyn Lineen summaries the article, " Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Receptor Positive, HER2-Negative Early-Stage Breast Cancer ," by Nassar et al. TRANSCRIPT Carolyn Lineen: Hello and welcome to JCO Precision Oncology Ar...

ctDNA in Metastatic Invasive Lobular Carcinoma 18.02.2026

JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, " Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast. " Host Dr. Rafeh Naqash and Dr. Foldi discuss how serial ctDNA testing in patie...

JCO PO Article Insights: Circulating Tumor DNA in Germ Cell Tumors 28.01.2026

In this JCO Precision Oncology Article Insights episode, host Dr. Jiasen He summaries the article, " Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors ," by Hassoun et al. TRANSCRIPT Jiasen He : Hello, and welcome to the JCO Precision Oncology Article Insights . I'm your host, Jiasen He, and today, we'll be discussin...

FGFR2b Prevalence in Advanced GC: FORTITUDE-101 Prescreening 21.01.2026

JCO PO author Dr. Wainberg at UCLA shares insights into the JCO PO article, "Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial." Host Dr. Rafeh Naqash and Dr. Wainberg discuss how FGFR2b prevalence was similar across geographic regions and within defined patient and sample variables regardless of the level of expressio...

Palbociclib in Tumors with CDKN2A Loss or Mutation 07.01.2026

In this JCO Precision Oncology Article Insights episode, host Dr. Harold Nathan Tan summarizes " Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study " by Worden et al.  TRANSCRIPT Harold Nathan Tan : Welcome to JCO Precision Oncology Article Insights , where we explore research that is...

FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer 17.12.2025

JCO PO author Dr. Shilpa Gupta at Cleveland Clinic Children's Hospital shares insights into her article, " Fibroblast Growth Factor Receptor 3 (FGFR3) Alteration Status and Outcomes on Immune Checkpoint Inhibitors (ICPI) in Patients with Metastatic Urothelial Carcinoma ". Host Dr. Rafeh Naqash and Dr. Gupta discuss how FGFR3 combined with TMB emerged as a biomarker that may be predictive for respo...

JCO PO Article Insights: Genomic Risk Classifiers in Localized Prostate Cancer 26.11.2025

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized " by Góes et al. published on September 10, 2025. TRANSCRIPT Natalie DelRocco: Hello and welcome to JCO Precision Oncology Article Insights . I'm your host, Natalie DelRocco, and today we will be discussing the editorial " Genomi...

DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas 19.11.2025

Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, " Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas "  Host Dr. Rafeh Naqash and Drs. Ross and Cooper discuss the landscape of Delta-like ligand 3 (DLL3) and seizure-related homolog protein 6 (SEZ6) across NECs from eight differ...

Listen to the JCO Precision Oncology Conversations podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.